Ranking the impact of human health disorders on gut metabolism: Systemic lupus erythematosus and obesity as study cases

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rojo, David ^a   Hevia, Arancha ^b   Bargiela, Rafael ^c   López, Patricia ^d   Cuervo, Adriana ^d   González, Sonia ^d   Suárez, Ana ^d   Sánchez, Borja ^c,i   Martínez Martínez, Mónica ^c   Milani, Christian ^e   Ventura, Marco ^e   Barbas, Coral ^a   Moya, Andrés ^f,g   Suárez, Antonio ^h   Margolles, Abelardo ^b   Ferrer, Manuel ^c  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^c INSTITUTO DE CATÁLISIS Y PETROLEOQUÍMICA   (Spain)

^d UNIVERSITY OF OVIEDO   (Spain)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY OF VALENCIA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h UNIVERSITY OF GRANADA   (Spain)

ⁱ UNIVERSITY OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLNEURAMINIC ACID;

ADULT; BODY MASS; CASE CONTROL STUDY; FEMALE; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; METABOLISM; METABOLOME; METABOLOMICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; OBESITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MICROBIOTA; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; OBESITY;

EID: 84928585305     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08310     Document Type: Article

References (35)

1. Greenblum, S., Turnbaugh, P. J. & Borenstein, E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 109, 594-599 (2012).
2. Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700-711 (2013).
3. Knecht, H. et al. Effects of b-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea. Plos One 9, e89417 (2014).
4. Theriot, C. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114 (2014).
5. Pérez-Cobas, A. E. et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62, 1591-1601 (2013).
6. Papathanasopoulos, A. & Camilleri, M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology 138, 65-72 (2010).
7. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
8. Spencer, M. D. et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140, 976-986 (2011).
9. Ursell, L. K. et al. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 146, 1470-1476 (2014).
10. Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nat. Innunol. 12, 5-9 (2011).
11. Hevia, A. et al. Intestinal dysbiosis associated with Systemic Lupus Erythematosus. mBio 5, e01548-14 (2014).
12. Li, L. et al. Murine lupus strains differentially model unique facets of human lupus serology. Clin. Exp. Immunol. 168, 178-188 (2012).
13. Parker, B. et al. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann. Rheum. Dis. 72, 1308-1314 (2013).
14. Díaz-Gallo, L. M. et al. Association study of BAK1 gene polymorphisms in Spanish rheumatoid arthritis and systemic lupus erythematosus cohorts. Ann. Rheum. Dis. 71, 314-316 (2012).
15. McMahon,M. et al. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum. 66, 130-139 (2014).
16. Toivanen, P.Normal intestinalmicrobiota in the aetiopathogenesis of rheumatoid arthritis. Ann. Rheum. Dis. 62, 807-811 (2003).
17. Hernández, E. et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 4, 306-315 (2013).
18. Bondia-Pons, I. et al. Metabolome and fecal microbiota in monozygotic twin pairs discordant for weight: a Big Mac challenge. FASEB J. pii, fj.14-250167 (2014).
19. Sio, C. F. et al. Quorum quenching by an N-acyl-homoserine lactone acylase from Pseudomonas aeruginosa PAO1. Infect. Immun. 74, 1673-1682 (2006).
20. Dong, Y. H. & Zhang, L. H. Quorum sensing and quorum-quenching enzymes. J. Microbiol. 43, 101-109 (2005).
21. Chen, F., Gao, Y., Chen, X., Yu, Z. & Li, X. Quorum quenching enzymes and their application in degrading signal molecules to block quorum sensing-dependent infection. Int. J. Mol. Sci. 14, 17477-17500 (2013).
22. Kawaguchi, T. Chen, Y. P., Norman, R. S. & Decho, A. W. Rapid screening of quorum-sensing signal N-acyl homoserine lactones by an in vitro cell-free assay. Appl. Environ. Microbiol. 74, 3667-3671 (2008).
23. Riedel, K. et al. N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147, 3249-3262 (2011).
24. Zhang, X. El-Hajj, Z. W. & Newman, E. Deficiency in L-serine deaminase interferes with one-carbon metabolism and cell wall synthesis in Escherichia coli K-12. J. Bacteriol. 192, 5515-5525 (2010).
25. McDonald, C., Inohara, N. & Nuñez, G. Peptidoglycan signaling in innate immunity and inflammatory disease. J. Biol. Chem. 280, 20177-20180 (2005).
26. Konopka, J. B. N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica 2012, 489208 (2012).
27. Beale, S. I. & Foley, T. Induction of delta-aminolevulinic acid synthase activity and inhibition of heme synthesis in Euglena gracilis by N-methyl mesoporphyrin IX. Plant Physiol. 69, 1331-1333 (1982).
28. Ng, K. M. et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99 (2013).
29. Walker, A. et al. Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J. 8, 2380-2396 (2014).
30. Le Gall, et al. Metabolomics of fecal extracts detects altered metabolic activity of gutmicrobiota in ulcerative colitis and irritable bowel syndrome. J. Proteome Res. 10, 4208-4218 (2011).
31. Marcobal, A. et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 7, 1933-1943 (2013).
32. Saric, J. et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J. Proteome Res. 7, 352-360 (2008).
33. Weir, T. L. et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. Plos One 8, e70803 (2013).
34. Kibe, R. et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice. Sci. Rep. 4, 4548 (2014).
35. Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060-1083 (2011).